Hypothermic versus Normothermic Temperature Control after Cardiac Arrest
Language English Country United States Media print-electronic
Document type Meta-Analysis, Journal Article
PubMed
38319850
DOI
10.1056/evidoa2200137
Knihovny.cz E-resources
- MeSH
- Hypothermia * MeSH
- Humans MeSH
- Heart Arrest * therapy MeSH
- Body Temperature MeSH
- Temperature MeSH
- Hypothermia, Induced * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Meta-Analysis MeSH
BACKGROUND: The evidence for temperature control for comatose survivors of cardiac arrest is inconclusive. Controversy exists as to whether the effects of hypothermia differ per the circumstances of the cardiac arrest or patient characteristics. METHODS: An individual patient data meta-analysis of the Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest (TTM) and Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trials was conducted. The intervention was hypothermia at 33°C and the comparator was normothermia. The primary outcome was all-cause mortality at 6 months. Secondary outcomes included poor functional outcome (modified Rankin scale score of 4 to 6) at 6 months. Predefined subgroups based on the design variables in the original trials were tested for interaction with the intervention as follows: age (older or younger than the median), sex (female or male), initial cardiac rhythm (shockable or nonshockable), time to return of spontaneous circulation (above or below the median), and circulatory shock on admission (presence or absence). RESULTS: The primary analyses included 2800 patients, with 1403 assigned to hypothermia and 1397 to normothermia. Death occurred for 691 of 1398 participants (49.4%) in the hypothermia group and 666 of 1391 participants (47.9%) in the normothermia group (relative risk with hypothermia, 1.03; 95% confidence interval [CI], 0.96 to 1.11; P=0.41). A poor functional outcome occurred for 733 of 1350 participants (54.3%) in the hypothermia group and 718 of 1330 participants (54.0%) in the normothermia group (relative risk with hypothermia, 1.01; 95% CI, 0.94 to 1.08; P=0.88). Outcomes were consistent in the predefined subgroups. CONCLUSIONS: Hypothermia at 33°C did not decrease 6-month mortality compared with normothermia after out-of-hospital cardiac arrest. (Funded by Vetenskapsrådet; ClinicalTrials.gov numbers NCT02908308 and NCT01020916.)
Adult Critical Care University Hospital of Wales Cardiff United Kingdom
Anglia Ruskin School of Medicine Chelmsford Essex United Kingdom
Australian and New Zealand Intensive Care Research Centre Monash University Melbourne Australia
Clinical Studies Sweden Forum South Skåne University Hospital Lund Sweden
Cochin University Hospital Descartes University of Paris Paris
Department of Cardiology The Heart Centre Copenhagen University Hospital Rigshospitalet Copenhagen
Department of Emergency Medicine University of Pittsburgh Pittsburgh
Department of Intensive Care Academic Medical Center Amsterdam
Department of Intensive Care Bristol Royal Infirmary Bristol United Kingdom
Department of Intensive Care Erasme University Hospital Université Libre de Bruxelles Brussels
Department of Intensive Care Liverpool Hospital Sydney
Department of Intensive Care Medical Center Leeuwarden Leeuwarden The Netherlands
Department of Intensive Care Medicine Centre Hospitalier de Luxembourg Luxembourg Luxembourg
Department of Nephrology and Medical Intensive Care Charité Universitätsmedizin Berlin Berlin
Department of Surgical Sciences and Integrated Diagnostics University of Genoa Genoa Italy
Division of Critical Care and Trauma George Institute for Global Health Sydney
Essex Cardiothoracic Centre Basildon United Kingdom
Intensive Care Department Kantonspital St Gallen St Gallen Switzerland
Intensive Care Unit Santa Maria degli Angeli Pordenone Italy
Klinik und Hochschulambulanz für Neurologie Charité Universitätzmedizin Berlin
Neurology Department of Clinical Sciences Skåne University Hospital Lund Lund University Lund Sweden
University College Dublin Clinical Research Centre St Vincent's University Hospital Dublin
References provided by Crossref.org
ClinicalTrials.gov
NCT02908308, NCT01020916